Skip to main content

Table 2 The incidence rate of the tumour at different sites

From: The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer

Group

Organ

Malignant Ascites (%)

Pancreas

Liver

Spleen

Peritoneum

Mesentery

Lung

PANC-MUC4/Y vs PANC-EV

8/8 vs 8/8

8/8 vs 1/8

8/8 vs 8/8

4/8 vs 1/8

4/8 vs 0/8

5/8 vs 0/8

4/8 vs 0/8

P > 0.05

P < 0.01

P > 0.05

P > 0.05

P < 0.05

P < 0.05

P < 0.05

PANC-MUC4/Y vs PANC-MUC4/Y-AMOPΔ

8/8 vs 8/8

8/8 vs 2/8

8/8 vs 8/8

4/8 vs 1/8

4/8 vs 0/8

5/8 vs 0/8

4/8 vs 0/8

P > 0.05

P < 0.01

P > 0.05

P > 0.05

P < 0.05

P < 0.05

P < 0.05

PANC-EV vs PANC-MUC4/Y-AMOPΔ

8/8 vs 8/8

1/8 vs 2/8

8/8 vs 8/8

1/8 vs 1/8

0/8 vs 0/8

0/8 vs 0/8

0/8 vs 0/8

P > 0.05

P > 0.05

P > 0.05

P > 0.05

P > 0.05

P > 0.05

P > 0.05